Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cosmetic Surgery Market
5.1. COVID-19 Landscape: Cosmetic Surgery Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Cosmetic Surgery Market, By Procedure
8.1. Cosmetic Surgery Market, by Procedure, 2022-2030
8.1.1. Surgical Procedures
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Non-surgical Procedures
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Cosmetic Surgery Market, By Gender
9.1. Cosmetic Surgery Market, by Gender, 2022-2030
9.1.1. Male
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Female
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Cosmetic Surgery Market, By Age
10.1. Cosmetic Surgery Market, by Age, 2022-2030
10.1.1. 13 - 29
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. 30 - 54
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. 55 plus
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Cosmetic Surgery Market, By End User
11.1. Cosmetic Surgery Market, by End User, 2022-2030
11.1.1. Ambulatory Surgical Facility
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Hospital and Clinic
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Others
11.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Cosmetic Surgery Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.1.2. Market Revenue and Forecast, by Gender (2017-2030)
12.1.3. Market Revenue and Forecast, by Age (2017-2030)
12.1.4. Market Revenue and Forecast, by End User (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Gender (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Age (2017-2030)
12.1.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Gender (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Age (2017-2030)
12.1.6.4. Market Revenue and Forecast, by End User (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.2.2. Market Revenue and Forecast, by Gender (2017-2030)
12.2.3. Market Revenue and Forecast, by Age (2017-2030)
12.2.4. Market Revenue and Forecast, by End User (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Gender (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Age (2017-2030)
12.2.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Gender (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Age (2017-2030)
12.2.6.4. Market Revenue and Forecast, by End User (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Gender (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Age (2017-2030)
12.2.7.4. Market Revenue and Forecast, by End User (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Gender (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Age (2017-2030)
12.2.8.4. Market Revenue and Forecast, by End User (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.3.2. Market Revenue and Forecast, by Gender (2017-2030)
12.3.3. Market Revenue and Forecast, by Age (2017-2030)
12.3.4. Market Revenue and Forecast, by End User (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Gender (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Age (2017-2030)
12.3.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Gender (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Age (2017-2030)
12.3.6.4. Market Revenue and Forecast, by End User (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Gender (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Age (2017-2030)
12.3.7.4. Market Revenue and Forecast, by End User (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Gender (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Age (2017-2030)
12.3.8.4. Market Revenue and Forecast, by End User (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.4.2. Market Revenue and Forecast, by Gender (2017-2030)
12.4.3. Market Revenue and Forecast, by Age (2017-2030)
12.4.4. Market Revenue and Forecast, by End User (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Gender (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Age (2017-2030)
12.4.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Gender (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Age (2017-2030)
12.4.6.4. Market Revenue and Forecast, by End User (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Gender (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Age (2017-2030)
12.4.7.4. Market Revenue and Forecast, by End User (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Gender (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Age (2017-2030)
12.4.8.4. Market Revenue and Forecast, by End User (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.5.2. Market Revenue and Forecast, by Gender (2017-2030)
12.5.3. Market Revenue and Forecast, by Age (2017-2030)
12.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Gender (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Age (2017-2030)
12.5.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Procedure (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Gender (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Age (2017-2030)
12.5.6.4. Market Revenue and Forecast, by End User (2017-2030)
Chapter 13. Company Profiles
13.1. Evolus Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. RevanceGalderma
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. AbbVie
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Cynosure
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Lumenis
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Solta Medical
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Alma Laser
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Syneron Candela
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client